Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 24, 1998

View Archived Issues

Tin complexes with antitumor activity disclosed by Pharmachemie

Antitumor agents isolated from Streptomyces by Japanese lab

Future antiglaucoma drug candidates added to the pipeline at Alcon

Potential cardiovascular agents act by increasing HDL cholesterol

MRI contrast agents reported by Hoechst Celanese

MDL-103294 and related antioxidants described by Hoechst Marion Roussel

Novel cysteine protease inhibitors discussed by BASF

Company Profile: Arachnova

Wound-healing asiatic acid derivatives under investigation at Dong Kook

Antimuscarinic agent KRP-197 shows potential for treating incontinence

Thymosin alpha 1 receives patent protection for hepatitis C indication

New indication approved for AmBisome in the U.K.

Corvas and Schering-Plough discontinue collaboration; other projects remain on track

Phytera and Tsumura Juntendo expand research collaboration

Access licensee files for U.K. approval of amlexanox oral paste

Fungal enzyme inhibitors synthesized at Nippon Roche

GeneMedicine reports progress in its development of dendritic cell-based genetic vaccines

EU approval granted for Novo's orally active antidiabetic agent NovoNorm

First European filing for TOBI

Antiinvasive activity demonstrated with Servier's zinc chelator/MMP inhibitor

Fluoroquinolone antibacterial available for licensing from Dong Wha

Imutec receives patent protection for Virulizin in Canada

Strategy to improve the bioavailability of anthelmintic agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Deals and an M&A strengthen end-of-year numbers
BioWorld
Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...